
DOI . ORG {
}
Title[redir]:
Distinct histone modifications denote early stress-induced drug tolerance in cancer | Oncotarget
Description:
// Abdullah Al Emran 1,* , Diego M. Marzese 2,* , Dinoop Ravindran Menon 1 , Mitchell S. Stark 1 , Joachim Torrano 1 , Heinz Hammerlindl 1 , Gao Zhang 4 , Patricia Brafford 4 , Matthew P. Salomon 2 , Nellie Nelson 3 , Sabrina Hammerlindl 1 , Deepesh Gupta 1 , Gordon B. Mills 5 , Yiling Lu 5 , Richard A. Sturm 1 , Keith Flaherty 6 , Dave S. B. Hoon 2 , Brian Gabrielli 7 , Meenhard Herlyn 4 and Helmut Schaider 1 1 Dermatology Research Centre, The University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, Australia 2 Department of Translational Molecular Medicine, John Wayne Cancer Institute, Santa Monica, CA, USA 3 Sequencing Center, John Wayne Cancer Institute, Santa Monica, CA, USA 4 The Wistar Institute, Philadelphia, PA, USA 5 MD Anderson Centre, Houston, TX, USA 6 Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA 7 Mater Research Institute, Translational Research Institute, The University of Queensland, Woolloongabba, Queensland, Australia * These authors have contributed equally to this study Correspondence to: Helmut Schaider, email: // Keywords : acquired drug resistance; stress-induced resistance; histone modification; DNA methylation; epigenetic reprogramming Received : October 07, 2017 Accepted : November 26, 2017 Published : December 24, 2017 Abstract Besides somatic mutations or drug efflux, epigenetic reprogramming can lead to acquired drug resistance. We recently have identified early stress-induced multi-drug tolerant cancer cells termed induced drug-tolerant cells (IDTCs). Here, IDTCs were generated using different types of cancer cell lines; melanoma, lung, breast and colon cancer. A common loss of the H3K4me3 and H3K27me3 and gain of H3K9me3 mark was observed as a significant response to drug exposure or nutrient starvation in IDTCs. These epigenetic changes were reversible upon drug holidays. Microarray, qRT-PCR and protein expression data confirmed the up-regulation of histone methyltransferases (SETDB1 and SETDB2) which contribute to the accumulation of H3K9me3 concomitantly in the different cancer types. Genome-wide studies suggest that transcriptional repression of genes is due to concordant loss of H3K4me3 and regional increment of H3K9me3. Conversely, genome-wide CpG site-specific DNA methylation showed no common changes at the IDTC state. This suggests that distinct histone methylation patterns rather than DNA methylation are driving the transition from parental to IDTCs. In addition, silencing of SETDB1/2 reversed multi drug tolerance. Alterations of histone marks in early multi-drug tolerance with an increment in H3K9me3 and loss of H3K4me3/H3K27me3 is neither exclusive for any particular stress response nor cancer type specific but rather a generic response.
Matching Content Categories {π}
- Science
- Health & Fitness
- Education
Content Management System {π}
What CMS is doi.org built with?
Custom-built
No common CMS systems were detected on Doi.org, and no known web development framework was identified.
Traffic Estimate {π}
What is the average monthly size of doi.org audience?
π Respectable Traffic: 10k - 20k visitors per month
Based on our best estimate, this website will receive around 10,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Doi.org Make Money? {πΈ}
We find it hard to spot revenue streams.
Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Doi.org might be making money, but it's not detectable how they're doing it.
Keywords {π}
hkme, idtcs, cells, cancer, histone, drug, figure, cell, doi, methylation, resistance, dna, setdb, expression, parental, genes, modifications, melanoma, supplementary, mark, response, idtc, signalling, compared, performed, research, gene, repressive, epigenetic, state, days, control, docetaxel, genomewide, types, loss, significant, early, tolerance, usa, observed, data, transcriptional, stress, drugs, global, exposed, doxorubicin, oncotarget, generated,
Topics {βοΈ}
induced drug-tolerant cells early multi-drug tolerance multi-drug tolerance promoted genome-wide chromatin accessibility stress-induced drug tolerance thermo fisher scientific substantial global hyper-methylation drug holiday-induced sensitivity genome-wide differential expression significant genome-wide downregulation common stress-induced transition sequence alignment/map format multi-drug resistance potential interferon-related gene signature retinoblastoma tumor-suppressor gene exploring deep-sequencing data genome-wide studies suggest mann-whitney unpaired test raf/ras/mek/erk cancer type-specific program free publication identifying chip-seq enrichment open-access journal dedicated publication alerts subscribe transcriptional enhancer-repressive modification identified cell type-specific slow-cycling melanoma cells supplementary figure 8c-8e paired match-patient expression rna-seq data showed drug-tolerant model induced drug tolerance triple-negative breast cancer chip-seq peaks 20kb stress-induced resistance cell-type specific response genome-wide redistribution genome-wide expression genome-wide levels stat/ifn signalling linked methyl transferase activity global dna methylation early drug tolerance braf-mek-erk1/2 signalling survive early stress inaugural editorial editorial note 5mg/ml glucose media dna methylation patterns acute myeloid leukemia
Questions {β}
- Do beta-tubulin mutations have a role in resistance to chemotherapy?
Schema {πΊοΈ}
Article:
license:https://creativecommons.org/licenses/by/4.0/
publisher:
type:Organization
name:Oncotarget
logo:
type:ImageObject
url:https://www.oncotarget.com/images/oncotarget-logo-square.png
width:1200
height:1200
dateModified:2018-02-02T07:09:00Z
mainEntityOfPage:
type:WebPage
id:https://www.oncotarget.com/article/23654/text/
headline:Distinct histone modifications denote early stress-induced drug tolerance in cancer
articleSection:Priority Research Papers
sameAs:https://doi.org/10.18632/oncotarget.23654
image:https://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=viewFile&path%5B%5D=23654&path%5B%5D=74469&path%5B%5D=332294
datePublished:2017-12-24T00:00:00Z
author:
type:Person
name:Al Emran, Abdullah
type:Person
name:Marzese, Diego M.
type:Person
name:Menon, Dinoop Ravindran
type:Person
name:Stark, Mitchell S.
type:Person
name:Torrano, Joachim
type:Person
name:Hammerlindl, Heinz
type:Person
name:Zhang, Gao
type:Person
name:Brafford, Patricia
type:Person
name:Salomon, Matthew P.
type:Person
name:Nelson, Nellie
type:Person
name:Hammerlindl, Sabrina
type:Person
name:Gupta, Deepesh
type:Person
name:Mills, Gordon B.
type:Person
name:Lu, Yiling
type:Person
name:Sturm, Richard A.
type:Person
name:Flaherty, Keith
type:Person
name:Hoon, Dave S. B.
type:Person
name:Gabrielli, Brian
type:Person
name:Herlyn, Meenhard
type:Person
name:Schaider, Helmut
Organization:
name:Oncotarget
logo:
type:ImageObject
url:https://www.oncotarget.com/images/oncotarget-logo-square.png
width:1200
height:1200
ImageObject:
url:https://www.oncotarget.com/images/oncotarget-logo-square.png
width:1200
height:1200
WebPage:
id:https://www.oncotarget.com/article/23654/text/
Person:
name:Al Emran, Abdullah
name:Marzese, Diego M.
name:Menon, Dinoop Ravindran
name:Stark, Mitchell S.
name:Torrano, Joachim
name:Hammerlindl, Heinz
name:Zhang, Gao
name:Brafford, Patricia
name:Salomon, Matthew P.
name:Nelson, Nellie
name:Hammerlindl, Sabrina
name:Gupta, Deepesh
name:Mills, Gordon B.
name:Lu, Yiling
name:Sturm, Richard A.
name:Flaherty, Keith
name:Hoon, Dave S. B.
name:Gabrielli, Brian
name:Herlyn, Meenhard
name:Schaider, Helmut
Social Networks {π}(6)
External Links {π}(89)
- How much profit does https://www.oncotarget.com/article/23654/text/ make?
- Learn about the earnings of https://www.oncotarget.com/article/23654/text/editorial-board/
- What's the monthly income of http://oncotarget.msubmit.net?
- How much does https://www.oncotarget.com/article/23654/text/archive/v16/ net monthly?
- https://www.oncotarget.com/article/23654/text/archive/ income
- How much money does https://www.oncotarget.com/article/23654/text/scientific-integrity/ generate?
- How much does https://www.oncotarget.com/article/23654/text/editorial-policies/ pull in?
- Financial intake of https://www.oncotarget.com/article/23654/text/ethics-statement/
- Get to know https://www.oncotarget.com/article/23654/text/collections/'s earnings
- How much does https://www.oncotarget.com/article/23654/text/videos/interview/ net monthly?
- How much does https://www.oncotarget.com/article/23654/text/news/pr/ rake in every month?
- What's the financial outcome of https://www.oncotarget.com/article/23654/text/news/conferences/?
- How much money does https://www.oncotarget.com/article/23654/text/search/ generate?
- https://www.oncotarget.com/article/23654/text/contact/'s financial summary
- Find out how much https://www.oncotarget.com/article/101/ earns monthly
- How much does https://www.oncotarget.com/article/23654/text/subscribe/ pull in?
- Learn how profitable https://cancer.c2pforum.com/ is on a monthly basis
- How much income is https://www.oncoscience.us/ earning monthly?
- How much money does https://www.oncotarget.com/article/23654/text/editorial-policies/#post-publication-promotion generate?
- How much profit is https://www.impactjournals.com/ making per month?
- How much profit does https://wellcome.org/ make?
- How much does https://www.sspnet.org/ earn?
- What are the total earnings of https://www.oncotarget.com/article/23654/text/archive/v9/i9/?
- https://www.oncotarget.com/article/23654/pdf/'s financial summary
- https://www.oncotarget.com/article/23654/text/javascript:openRTWindow('https://www.oncotarget.com/index.php?journal=oncotarget&page=rt&op=suppFiles&path%5B%5D=23654&path%5B%5D=74469');'s revenue stream
- What's the profit of https://www.oncotarget.com/article/23654/text/javascript:openRTWindow('https://www.oncotarget.com/index.php?journal=oncotarget&page=rt&op=captureCite&path%5B%5D=23654&path%5B%5D=74469');?
- Get to know https://www.oncotarget.com/article/23654/text/mailto:%68.%73%63%68%61%69%64%65%72@%75%71.%65%64%75.%61%75's earnings
- How profitable is https://www.oncotarget.com/article/23654/text/mailto:[email protected]?
- What's the financial intake of https://www.oncotarget.com/article/23654/text/#bib1?
- What's the revenue for https://www.oncotarget.com/article/23654/text/#bib3?
- Get to know https://www.oncotarget.com/article/23654/text/#bib4's earnings
- Discover the revenue of https://www.oncotarget.com/article/23654/text/#bib5
- How much profit is https://www.oncotarget.com/article/23654/text/#bib6 making per month?
- Get to know https://www.oncotarget.com/article/23654/text/#bib7's earnings
- What's https://www.oncotarget.com/article/23654/text/#bib8's gross income?
- How much cash flow does https://www.oncotarget.com/article/23654/text/#bib9 have monthly?
- https://www.oncotarget.com/article/23654/text/#bib10 income
- Get to know what's the income of https://www.oncotarget.com/article/23654/text/#bib11
- Check the income stats for https://www.oncotarget.com/article/23654/text/#bib12
- See how much https://www.oncotarget.com/article/23654/text/#bib13 makes per month
- Learn about the earnings of https://www.oncotarget.com/article/23654/text/#bib14
- How much profit is https://www.oncotarget.com/article/23654/text/#bib15 making per month?
- How much income is https://www.oncotarget.com/article/23654/text/#bib16 earning monthly?
- How much revenue does https://www.oncotarget.com/article/23654/text/#bib17 bring in?
- What's https://www.oncotarget.com/article/23654/text/#F1's gross income?
- How much does https://www.oncotarget.com/article/23654/text/#F2 rake in every month?
- Earnings of https://www.oncotarget.com/article/23654/text/#bib18
- How much does https://www.oncotarget.com/article/23654/text/#bib19 net monthly?
- What's the monthly money flow for https://www.oncotarget.com/article/23654/text/#bib20?
- Financial intake of https://www.oncotarget.com/article/23654/text/#F3
- How much does https://www.oncotarget.com/article/23654/text/#bib54 rake in every month?
- How profitable is https://www.oncotarget.com/article/23654/text/#bib21?
- How much does https://www.oncotarget.com/article/23654/text/#bib22 pull in?
- https://www.oncotarget.com/article/23654/text/#F4's financial summary
- Learn about the earnings of https://www.oncotarget.com/article/23654/text/#bib23
- Learn how profitable https://epilogos.altiusinstitute.org/ is on a monthly basis
- Earnings of https://www.oncotarget.com/article/23654/text/#bib24
- Get to know what's the income of https://www.oncotarget.com/article/23654/text/#F5
- Profit of https://www.oncotarget.com/article/23654/text/#bib55
- How much does https://www.oncotarget.com/article/23654/text/#F6 pull in?
- What's the financial intake of https://www.oncotarget.com/article/23654/text/#bib25?
- Revenue of https://www.oncotarget.com/article/23654/text/#bib27
- How much does https://www.oncotarget.com/article/23654/text/#bib28 pull in monthly?
- Earnings of https://www.oncotarget.com/article/23654/text/#bib30
- What's the monthly income of https://www.oncotarget.com/article/23654/text/#bib31?
- How much does https://www.oncotarget.com/article/23654/text/#bib32 earn?
- Get to know what's the income of https://www.oncotarget.com/article/23654/text/#bib33
- https://www.oncotarget.com/article/23654/text/#bib34's revenue stream
- Discover the revenue of https://www.oncotarget.com/article/23654/text/#bib35
- What's the financial outcome of https://www.oncotarget.com/article/23654/text/#bib36?
- Financial intake of https://www.oncotarget.com/article/23654/text/#bib37
- How much cash flow does https://www.oncotarget.com/article/23654/text/#bib38 have monthly?
- Income figures for https://www.oncotarget.com/article/23654/text/#bib39
- What's the income generated by https://www.oncotarget.com/article/23654/text/#bib40 each month?
- What's the revenue for https://www.oncotarget.com/article/23654/text/#bib41?
- What's the income generated by https://www.oncotarget.com/article/23654/text/#bib42 each month?
- What's the income generated by https://www.oncotarget.com/article/23654/text/#bib43 each month?
- Monthly income for https://www.oncotarget.com/article/23654/text/#bib44
- https://www.oncotarget.com/article/23654/text/#bib45's total income per month
- How much income is https://www.oncotarget.com/article/23654/text/#bib46 earning monthly?
- What is the earnings of https://www.oncotarget.com/article/23654/text/#bib47?
- https://www.oncotarget.com/article/23654/text/#bib48's revenue stream
- How much does https://www.oncotarget.com/article/23654/text/#bib49 rake in every month?
- How much does https://www.oncotarget.com/article/23654/text/#bib50 generate monthly?
- Explore the financials of http://broadinstitute.github.io/picard/
- How much income is https://www.oncotarget.com/article/23654/text/#bib51 earning monthly?
- https://www.oncotarget.com/article/23654/text/#bib52 income
- How much cash flow does https://www.oncotarget.com/article/23654/text/#bib53 have monthly?
- Monthly income for https://creativecommons.org/licenses/by/4.0/
Analytics and Tracking {π}
- Google Analytics
- Google Analytics 4
- Google Tag Manager
- Google Universal Analytics
Libraries {π}
- Foundation
- jQuery
Emails and Hosting {βοΈ}
Mail Servers:
- mx.zoho.eu
- mx2.zoho.eu
- mx3.zoho.eu
Name Servers:
- josh.ns.cloudflare.com
- zita.ns.cloudflare.com
CDN Services {π¦}
- Cloudflare